These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18427534)

  • 1. [Clinical and electrophysiological peculiarities of seronegative myasthenia].
    Shcherbakova NI; Sanadze AG; Sidnev DV; Rudnichenko VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):4-10. PubMed ID: 18427534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myasthenia gravis in children: clinical study of 77 patients].
    Zhou SZ; Li WH; Sun DK
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):256-9. PubMed ID: 15157383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seronegative myasthenia gravis.
    Vincent A; McConville J; Farrugia ME; Newsom-Davis J
    Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sera from seronegative myasthenia gravis patients on neuromuscular junctions.
    Sato R; Imamoto S; Utsnomiya I; Chiba T; Taguchi K; Abe K; Tanaka K; Miyatake T
    Neurol Sci; 2013 Oct; 34(10):1735-44. PubMed ID: 23389808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological and clinical features of patients with myasthenia gravis in north Indian population.
    Suhail H; Subbiah V; Singh S; Behari M
    Int J Neurosci; 2010 Feb; 120(2):115-9. PubMed ID: 20199203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.
    Toth C; McDonald D; Oger J; Brownell K
    Acta Neurol Scand; 2006 Aug; 114(2):124-32. PubMed ID: 16867036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement.
    Scuderi F; Marino M; Colonna L; Mannella F; Evoli A; Provenzano C; Bartoccioni E
    Lab Invest; 2002 Sep; 82(9):1139-46. PubMed ID: 12218074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different characteristic phenotypes according to antibody in myasthenia gravis.
    Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
    J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
    Blaes F; Beeson D; Plested P; Lang B; Vincent A
    Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic hyperactivity in patients with myasthenia gravis with MuSK antibodies: A neurophysiological study.
    Modoni A; Mastrorosa A; Spagni G; Evoli A
    Clin Neurophysiol; 2021 Aug; 132(8):1845-1849. PubMed ID: 34147009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients.
    Padua L; Tonali P; Aprile I; Caliandro P; Bartoccioni E; Evoli A
    Eur J Neurol; 2006 Mar; 13(3):273-6. PubMed ID: 16618345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
    Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
    Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to clustered acetylcholine receptor: expanding the phenotype.
    Devic P; Petiot P; Simonet T; Stojkovic T; Delmont E; Franques J; Magot A; Vial C; Lagrange E; Nicot AS; Risson V; Eymard B; Schaeffer L
    Eur J Neurol; 2014; 21(1):130-4. PubMed ID: 24112557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortactin autoantibodies in myasthenia gravis.
    Gallardo E; Martínez-Hernández E; Titulaer MJ; Huijbers MG; Martínez MA; Ramos A; Querol L; Díaz-Manera J; Rojas-García R; Hayworth CR; Verschuuren JJ; Balice-Gordon R; Dalmau J; Illa I
    Autoimmun Rev; 2014 Oct; 13(10):1003-7. PubMed ID: 25193850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
    Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
    Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of thymectomy on seronegative generalized myasthenia gravis: comparing with seropositive cases.
    Yuan HK; Huang BS; Kung SY; Kao KP
    Acta Neurol Scand; 2007 Mar; 115(3):181-4. PubMed ID: 17295713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.